Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2003
08/21/2003US20030157609 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157608 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157607 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157606 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157605 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157604 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157603 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157602 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157601 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157599 Comprises nucleotide sequence coding prostaglandin E receptor (EP3) for diagnosis and treatment of atherosclerotic diseases; restriction fragment length polymorphisms
08/21/2003US20030157598 Membrane protein associated with nuclear factor activated t-cells for diagnosing and treating cell proliferative/kidney disorders
08/21/2003US20030157597 Nucleotide sequences coding 103P2D6-related protein for diagnosing various tumors; anticarcinogenic agents; genetic vaccines
08/21/2003US20030157589 Detecting bactericides/enzyme inhibitor which prevent propagtion of bacterium associated with tuberculosis and leprosy; desaturases (DES); drug screening
08/21/2003US20030157572 Determining phosphorylation state of a serine corresponding the residue 1981 of Ataxia-Telangiectasia Mutated kinase protein in a cell; the phosphorylation state of serine is indicative of activation state of ATM kinase
08/21/2003US20030157562 Protein is characterized in that it elicits an immunological response from a mammal; has been prepared by expression in a bacterium other than Borrelia burgdorferi; free of other Borrelia proteins and has specific amino acid sequence
08/21/2003US20030157552 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity
08/21/2003US20030157532 Anticancer agents; contraceptives; controlling gene expression
08/21/2003US20030157487 Nucleic acid ligands
08/21/2003US20030157485 Forensic analysis; chromosome marking
08/21/2003US20030157482 Binding labeled antibody to protein; measurement; calibration
08/21/2003US20030157479 Antigen arrays for treatment of allergic eosinophilic diseases
08/21/2003US20030157133 For treating, preventing, or inhibiting an infection or disease caused by a gram-positive organism including Streptococcus, Micrococcus, Lactobacillus, Staphylococcus, Bacillus, or Listeria
08/21/2003US20030157132 Remedies for hepatitis c
08/21/2003US20030157124 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157122 Streptococcal streptolysin S vaccines
08/21/2003US20030157119 Methods for diagnosis and therapy of hematological and virus-associated malignancies
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157116 Tlp peptides and dna sequences coding the same
08/21/2003US20030157112 Recombinant antibodies, and compositions and methods for making and using the same
08/21/2003US20030157109 Antibodies directed to PDGFD and uses thereof
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157106 Antibody which immunologically reacts with an interleukin 22 protein
08/21/2003US20030157105 Amino acid sequences
08/21/2003US20030157104 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
08/21/2003US20030157103 Human amine transporter antibodies
08/21/2003US20030157102 Administering a ligand having a population of activated t cells and binding specificity for the extracellular domain of CD28 to enhance t cell proliferation and increase overall lymphokine levels
08/21/2003US20030157100 Monoclonal antibody inducing apoptosis
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157098 Methods for inhibiting brain tumor growth
08/21/2003US20030157097 Novel remedies for cancer
08/21/2003US20030157096 Used to antagonize the effects of T-cell inducible factor in certain diseases
08/21/2003US20030157095 Invasive and metastic ability of breast cancer cells is proportional to level of peripheral type benzodiazepine receptor expressed, correlates with subcellular localization in that it is found in the nucleus of aggressive tumor cells
08/21/2003US20030157094 Prevention, therapy liver disorders, inflammatory bowel diseases, Crohn's disease; antiulcer agents; rheumatic diseases
08/21/2003US20030157093 Immunotoxin with in vivo t cell suppressant activity and methods of use
08/21/2003US20030157091 Computer analyzing; binding to polypeptide
08/21/2003US20030157090 Redox systems; accumulation of polypeptide in plant cell; genetic engineering
08/21/2003US20030157089 Polypeptides; inducting immunology response
08/21/2003US20030157063 Infection therapy; viricides; gene therapy; immunoglobulins
08/21/2003US20030157056 Modified cytokines for use in cancer therapy
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003US20030157054 Recombinant tumor specific antibody and use thereof
08/21/2003US20030155434 Spray nozzle apparatus and method of use
08/21/2003US20030154615 Measurement marking, scribing and scoring device
08/21/2003CA2752553A1 Anti-cd20 antibodies and fusion proteins thereof and methods of use
08/21/2003CA2482633A1 Oligomeric molecules and uses thereof
08/21/2003CA2482333A1 Human antibodies for therapy against vaccinia or smallpox
08/21/2003CA2476555A1 Methods of therapy and diagnosis
08/21/2003CA2476424A1 Means and methods for altering the motility of the gastrointestinal tract
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476237A1 Methods and apparatus for whole cell panning
08/21/2003CA2476232A1 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003CA2475929A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003CA2474943A1 Sugar stabilized antibody-containing solution formulations
08/21/2003CA2474885A1 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003CA2474782A1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
08/21/2003CA2474405A1 Medicament for the treatment of choroidal neovascularisation
08/21/2003CA2472922A1 Antibody variants with faster antigen association rates
08/21/2003CA2471392A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336850A1 Improved method for the detection of acid resistant microorganisms in a stool
08/20/2003EP1336848A1 Highly efficient method of screening antibody
08/20/2003EP1336654A1 Method of treating psoriasis using anti-gamma interferon antibody
08/20/2003EP1336620A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
08/20/2003EP1336109A1 Kit and method for detecting the esm-1 protein
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335931A2 Derivatisation of proteins in aqueous solution
08/20/2003EP1335746A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
08/20/2003EP1335745A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer
08/20/2003EP1147213A4 Novel rgs-containing molecules and uses thereof
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1047711B1 Nucleic acid sequences encoding capsaicin receptors
08/20/2003EP0861091B1 Immunotoxin containing a disulfide-stabilized antibody fragment
08/20/2003EP0817852B1 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
08/20/2003EP0672067B1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
08/20/2003CN1437654A Antigenic proteins of shrimp white spot syndrome virus uses thereof
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1437482A Recombinant or purified polyclonal antibodies for treating allergy
08/20/2003CN1437478A Intrathecal administration of Rituximab for treatment of central nervous system lymphomas
08/20/2003CN1118704C Reagent kit for diagnosing white-spot baculovirus of prawn and its testing method
08/20/2003CN1118571C Active protein with thrombopoietin
08/20/2003CN1118299C Gonococcal anti-idiotypic antibodies and using methods and composition thereof
08/19/2003US6608186 Pyranosyl nucleic acid conjugates
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608180 Nucleotide sequences coding preferential protein for use cancer treatment
08/19/2003US6608179 Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80)
08/19/2003US6608178 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
08/19/2003US6608172 Isolation of IgY (ΔFc) antibodies
08/19/2003US6608034 Immunovectors for the intracellular and intranuclear transport
08/19/2003US6608031 Peptide comprising specified amino acid sequence
1 ... 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 ... 1494